Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 39 out of 100. Risk genes beyond APOE

Topic: Brain proteins, microglia and lab models

Amyloid precursor protein (APP) is a key player in various neuronal functions but also the source for toxic Aβ that accumulates in the brain of Alzheimer patients. APP trafficking and processing depend on the endo -lysosomal system, but the molecular mechanisms that coordinate these processes remain not fully understood. Here, we studied the HOPS complex, a central regulator of endo-lysosomal maturation. We show that HOPS disruption impairs retromer-mediated recycling of APP to the TGN, resulting in the accumulation of APP in late endosomes. In neurons, this accumulation is spatially restricted to somatodendritic endosomes. These APP-containing endosomes are catalytically inactive and lack the γ-secretase subunit PSEN2. However, they do contain BACE1, which contributes to the build-up of toxic APP C-terminal fragments (APP-CTFs). Notably, loss of HOPS function enhances secretion of APP-CTFs by exosomes, suggesting a potential mechanism for disease propagation. Together, our findings establish a mechanistic link between HOPS loss-of-function and aberrant APP processing, with implications for neurodegeneration. • HOPS impairment blocks retromer-mediated recycling of APP to the TGN. • HOPS impairment redistributes APP to static late endosomes in soma and dendrites. • HOPS impairment increases APP and BACE1 colocalization, promoting APP-CTF formation. • APP-CTF positive late endosomes are catalytically inactive and lack PSEN2. • HOPS impaired cells secrete APP-CTFs by EVs, potentially promoting disease spread.

Key findings

Why it matters

This study shows that disruption of the HOPS complex impairs retromer-mediated recycling of APP, causing APP accumulation in late endosomes where BACE1 contributes to toxic APP C-terminal fragments, and enhances exosomal secretion of these fragments. The findings establish a mechanistic link between HOPS loss-of-function and aberrant APP processing, but they are laboratory results with implications for neurodegeneration rather than a demonstrated treatment.

Study details

How this study scored 39/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 4 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 39 of 100.39 of 100 points earned61 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Neurobiology of Disease)
Journal's citation record 2 / 4 Neurobiology of Disease: journal h-index 225 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 2 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.0 citations a year over 2 year(s) since 2026
Impact for its field and year 4 / 6 Cited 8.3× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Ginny G. Farı́as: h-index 27 (OpenAlex, whole career)
Institution's track record 1 / 3 Utrecht University: institution h-index 1,157 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41525887)
Free to read 2 / 2 Free to read
Total 39 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

APA 7th

Draper, D., George, A. E., Veenendaal, T., van Dijk, S. M., Soltani, E., Sanzà, P., et al. (2026). HOPS disruption impairs APP trafficking and processing, promoting exosomal secretion of APP-CTFs. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2026.107269

Vancouver

Draper D, George AE, Veenendaal T, van Dijk SM, Soltani E, Sanzà P, et al. HOPS disruption impairs APP trafficking and processing, promoting exosomal secretion of APP-CTFs. Neurobiology of Disease. 2026. doi:10.1016/j.nbd.2026.107269. PMID: 41525887.

BibTeX

@article{draper2026-41525887,
  author  = {Draper, Derk and George, Anna E. and Veenendaal, Tineke and van Dijk, Suzanne M. and Soltani, Elly and Sanzà, Paolo and Verweij, Frederik J. and Klumperman, Judith and others},
  title   = {{HOPS disruption impairs APP trafficking and processing, promoting exosomal secretion of APP-CTFs}},
  journal = {Neurobiology of Disease},
  year    = {2026},
  doi     = {10.1016/j.nbd.2026.107269},
  pmid    = {41525887},
  url     = {https://doi.org/10.1016/j.nbd.2026.107269}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Risk genes beyond APOE

Similar studies

More on Risk genes beyond APOE

See all studies in Risk genes beyond APOE →